PT  - JOURNAL ARTICLE
AU  - Xia, Lingfang
AU  - Peng, Jin
AU  - Lou, Ge
AU  - Pan, Mei
AU  - Zhou, Qi
AU  - Hu, Wenjing
AU  - Shi, Huirong
AU  - Wang, Li
AU  - Gao, Yunong
AU  - Zhu, Jianqing
AU  - Zhang, Yu
AU  - Sun, Rong
AU  - Zhou, Xianfeng
AU  - Wang, Quanren
AU  - Wu, Xiaohua
TI  - Antitumor activity and safety of camrelizumab plus famitinib in patients with platinum-resistant recurrent ovarian cancer: results from an open-label, multicenter phase 2 basket study
AID  - 10.1136/jitc-2021-003831
DP  - 2022 Jan 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - e003831
VI  - 10
IP  - 1
4099  - http://jitc.bmj.com/content/10/1/e003831.short
4100  - http://jitc.bmj.com/content/10/1/e003831.full
SO  - J Immunother Cancer2022 Jan 01; 10
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.